Pharmaceuticals

Pericarditis Market Research: Growth Projections and Trends 2030

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pericarditis market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Pericarditis Market from 2026 to 2030?

The pericarditis market size has experienced robust expansion in recent years. It is projected to increase from $2.49 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. In the historic period, this growth was influenced by factors such as limited awareness of pericarditis, a reliance on traditional diagnostic approaches, low adoption rates of advanced imaging, restricted access to specialized cardiac care, and the prevalence of hospital-based treatment.

The pericarditis market is anticipated to experience robust expansion over the next several years. It is projected to reach $3.64 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.9%. This growth during the forecast period stems from the increasing prevalence of cardiovascular disorders, greater adoption of digital diagnostics, the expansion of outpatient surgical centers, heightened investment in precision medicine, and the integration of AI within cardiac care. Significant trends expected in this period encompass personalized pericarditis treatment methods, minimally invasive surgical procedures, innovations in early diagnosis, the incorporation of wearable cardiac monitoring, and the broadening of outpatient cardiac care services.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9170&type=smp

What Drivers Are Affecting Demand In The Pericarditis Market?

The expanding occurrence of cardiovascular ailments is anticipated to drive the expansion of the pericarditis market in the future. Cardiovascular diseases encompass conditions that impact the heart or blood vessels, frequently associated with arterial fatty deposit accumulation and a heightened risk of blood clot formation. If left unaddressed, pericarditis can result in numerous cardiovascular complications or, in severe situations, lead to fatality, thus accelerating market growth due to the rising incidence of these diseases. For example, the American Heart Association, a US-based non-profit organization, reported in January 2024 that the age-adjusted mortality rate for cardiovascular disease climbed to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the growing prevalence of cardiovascular diseases is stimulating the growth of the pericarditis devices market.

Which Segment Groups Are Influencing The Pericarditis Market?

The pericarditis market covered in this report is segmented –

1) By Type: Acute Pericarditis, Chronic Pericarditis, Recurrent Pericarditis

2) By Diagnosis And Treatment: Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (Ct), X-Ray, Medication, Surgical Treatment

3) By Application: Hospitals And Clinics, Medical Institutes, Ambulatory Surgical Centers, Research Organizations

Subsegments:

1) By Acute Pericarditis: Viral Pericarditis, Bacterial Pericarditis, Idiopathic Pericarditis

2) By Chronic Pericarditis: Constrictive Pericarditis, Non-constrictive Chronic Pericarditis

3) By Recurrent Pericarditis: Post-Acute Pericarditis Recurrences, Secondary Recurrent Pericarditis

Which Trends Are Shaping Activity Within The Pericarditis Market?

Leading companies active in the pediatric market are developing advanced monoclonal antibodies to enhance treatment options, improve therapeutic outcomes, and minimize side effects for children suffering from various medical conditions. These next-generation monoclonal antibodies are engineered to deliver superior efficacy, specificity, and safety in targeting diseases. For instance, in January 2024, Coherus BioSciences, a US-based biotechnology company, introduced LOQTORZITM. LOQTORZI is utilized in conjunction with cisplatin and gemcitabine for the initial treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma (NPC). It can also be administered as a monotherapy for patients with recurrent, unresectable, or metastatic NPC who have progressed following platinum-containing chemotherapy, regardless of PD-L1 status.

Who Are The Core Companies Influencing Trends In The Pericarditis Market?

Major companies operating in the pericarditis market are Pfizer Inc., AstraZeneca plc, Merck & Co. Inc., Novartis International AG, Johnson & Johnson Services Inc., Takeda Pharmaceutical Co. Ltd., Zydus Cadila Healthcare Ltd., Sun Pharmaceutical Ltd., Kiniksa Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Amgen Inc., Merck KGaA, Hikma Pharmaceuticals plc, AbbVie Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Bayer AG, Roche Holding AG, Daiichi Sankyo Company Limited, Astellas Pharma Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pericarditis-global-market-report

Which Regions Are Projected To Dominate The Pericarditis Market In The Coming Years?

North America was the largest region in the pericarditis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the pericarditis market report during the forecast period. The regions covered in the pericarditis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pericarditis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9170&type=smp

Browse Through More Reports Similar to the Global Pericarditis Market 2026, By The Business Research Company

Pericarditis Market Report 2026

https://www.thebusinessresearchcompany.com/report/pericarditis-global-market-report

Peptic Ulcer Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Cardiac Valve Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795